Limitations to the use of bromelain-based enzymatic debridement (NexoBrid) for treating diabetic foot burns: a case series of disappointing results
Background: Bromelain-based enzymatic debridement with Nexobrid® (Mediwound) is an alternative to traditional surgical tangential excision of deep dermal and full thickness burns. Early literature suggests that Nexobrid debridement could reduce the number of operations, infection rates, inpatient st...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SAGE Publishing
2018-12-01
|
| Series: | Scars, Burns & Healing |
| Online Access: | https://doi.org/10.1177/2059513118816534 |